Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections
Status:
Terminated
Trial end date:
2020-10-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of delafloxacin administered
as IV and oral formulation in comparison with Best Available Therapy (BAT) in patients with
superficial or deep incisional surgical site infection following a cardiothoracic/related leg
or abdominal surgery.